NCT02057133 2026-01-26
A Study of LY2835219 (Abemaciclib) in Combination With Therapies for Breast Cancer That Has Spread
Eli Lilly and Company
Phase 1 Active not recruiting
Eli Lilly and Company
Puma Biotechnology, Inc.
Jiangsu HengRui Medicine Co., Ltd.
Eli Lilly and Company
AEterna Zentaris